-
3
-
-
24744431854
-
Neuropsychiatric symptoms and quality of life in Alzheimer disease
-
Shin IS, Carter M, Masterman D, Fairbanks L, Cummings JL. Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am J Geriatr Psychiatry. 2005;13:469-474.
-
(2005)
Am J Geriatr Psychiatry
, vol.13
, pp. 469-474
-
-
Shin, I.S.1
Carter, M.2
Masterman, D.3
Fairbanks, L.4
Cummings, J.L.5
-
4
-
-
0035190585
-
Alzheimer's disease and other dementia in nursing homes: Levels of management and cost
-
O'Brien JA, Caro JJ. Alzheimer's disease and other dementia in nursing homes: levels of management and cost. Int Psychogeriatr. 2001;13:347-358.
-
(2001)
Int Psychogeriatr
, vol.13
, pp. 347-358
-
-
O'Brien, J.A.1
Caro, J.J.2
-
5
-
-
0036288732
-
Estimating the relationship between disease progression and cost of care in dementia
-
Wolstenholme J, Fenn P, Gray A, et al. Estimating the relationship between disease progression and cost of care in dementia. Br J Psychiatry. 2002;181:36-42.
-
(2002)
Br J Psychiatry
, vol.181
, pp. 36-42
-
-
Wolstenholme, J.1
Fenn, P.2
Gray, A.3
-
6
-
-
0037321045
-
The incremental effect of dementia-related problem behaviors on the time to nursing home placement in poor, frail, demented older people
-
Phillips VL, Diwan S. The incremental effect of dementia-related problem behaviors on the time to nursing home placement in poor, frail, demented older people. J Am Geriatr Soc. 2003;51:188-193.
-
(2003)
J Am Geriatr Soc
, vol.51
, pp. 188-193
-
-
Phillips, V.L.1
Diwan, S.2
-
7
-
-
0031925574
-
Psychosocial and behavioral interventions for Alzheimer's disease patients and their families
-
Beck C. Psychosocial and behavioral interventions for Alzheimer's disease patients and their families. Am J Geriatr Psychiatry. 1998;6(2 suppl 1):S41-S48.
-
(1998)
Am J Geriatr Psychiatry
, vol.6
, Issue.2 SUPPL. 1
-
-
Beck, C.1
-
9
-
-
28944453427
-
-
East Hanover, NJ: Novartis Pharmaceuticals
-
Exelon (package insert). East Hanover, NJ: Novartis Pharmaceuticals; 2004.
-
(2004)
Exelon (Package Insert)
-
-
-
10
-
-
1242311898
-
-
St. Louis, MO; Forest Laboratories
-
Namenda (package insert). St. Louis, MO; Forest Laboratories; 2003.
-
(2003)
Namenda (Package Insert)
-
-
-
11
-
-
28944443009
-
-
Titusville, NJ: Ortho-McNeil Neurologics
-
Razadyne (package insert). Titusville, NJ: Ortho-McNeil Neurologics; 2005.
-
(2005)
Razadyne (Package Insert)
-
-
-
12
-
-
33846807625
-
The Expert Consensus Guideline Series: Pharmacotherapy in older patients
-
Oct special report
-
Alexopoulos GS, Katz IR, Reynolds CF, et al. The Expert Consensus Guideline Series: pharmacotherapy in older patients. Postgrad Med. 2001;110(Oct special report):1-86.
-
(2001)
Postgrad Med
, vol.110
, pp. 1-86
-
-
Alexopoulos, G.S.1
Katz, I.R.2
Reynolds, C.F.3
-
13
-
-
0035826771
-
Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
Doody RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1154-1166.
-
(2001)
Neurology
, vol.56
, pp. 1154-1166
-
-
Doody, R.S.1
Stevens, J.C.2
Beck, C.3
-
14
-
-
2942616386
-
Noncognitive symptoms and long-term treatment expectations for Alzheimer disease
-
Blesa R. Noncognitive symptoms and long-term treatment expectations for Alzheimer disease. Alzheimer Dis Assoc Disord. 2004;(18 suppl 1):S9-S16.
-
(2004)
Alzheimer Dis Assoc Disord
, Issue.18 SUPPL. 1
-
-
Blesa, R.1
-
15
-
-
0035964226
-
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
-
Feldman H, Gauthier S, Hecker J, et al. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology. 2001;57:613-620.
-
(2001)
Neurology
, vol.57
, pp. 613-620
-
-
Feldman, H.1
Gauthier, S.2
Hecker, J.3
-
16
-
-
0036942425
-
Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease
-
Gauthier S, Feldman H, Hecker J, et al. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatr. 2002;14:389-404.
-
(2002)
Int Psychogeriatr
, vol.14
, pp. 389-404
-
-
Gauthier, S.1
Feldman, H.2
Hecker, J.3
-
17
-
-
28944432437
-
-
Functional and behavioral effects of memantine in Alzheimer's disease. Poster presented; April 24-May 1, San Francisco, CA
-
Cummings JL, van Dyck C, Schmitt FA, et al. Functional and behavioral effects of memantine in Alzheimer's disease. Poster presented at: The 56th Annual Meeting of the American Academy of Neurology; April 24-May 1, 2004; San Francisco, CA.
-
(2004)
56th Annual Meeting of the American Academy of Neurology
-
-
Cummings, J.L.1
Van Dyck, C.2
Schmitt, F.A.3
-
18
-
-
28944452531
-
-
Effect of memantine on behavioral outcomes in Alzheimer's disease. Poster presented; April 9-16, Miami Beach, FL
-
Cummings JL, Schneider E., Peskind E, et al. Effect of memantine on behavioral outcomes in Alzheimer's disease. Poster presented at: 57th Annual Meeting of the American Academy of Neurology; April 9-16, 2005; Miami Beach, FL.
-
(2005)
57th Annual Meeting of the American Academy of Neurology
-
-
Cummings, J.L.1
Schneider, E.2
Peskind, E.3
-
19
-
-
23244442841
-
Increased mortality among elderly patients with dementia using atypical antipsychotics
-
Singh S, Wooltorton E. Increased mortality among elderly patients with dementia using atypical antipsychotics. CMAJ. 2005;173:252.
-
(2005)
CMAJ
, vol.173
, pp. 252
-
-
Singh, S.1
Wooltorton, E.2
-
20
-
-
14744273100
-
Treatment of behavioural and psychiatric symptoms in dementia: Implications of recent safety warnings
-
Bullock R. Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings. Curr Med Res Opin. 2005;21:1-10.
-
(2005)
Curr Med Res Opin
, vol.21
, pp. 1-10
-
-
Bullock, R.1
-
21
-
-
0035728196
-
Iatrogenic disorders associated with conventional vs. atypical antipsychotics
-
Nasrallah HA, Mulvihill T. Iatrogenic disorders associated with conventional vs. atypical antipsychotics. Ann Clin Psychiatry. 2001;13:215-227.
-
(2001)
Ann Clin Psychiatry
, vol.13
, pp. 215-227
-
-
Nasrallah, H.A.1
Mulvihill, T.2
-
22
-
-
4043100585
-
Behavioral and psychological symptoms in dementia: The role of atypical antipsychotics
-
Lawlor BA. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics. J Clin Psychiatry. 2004;65(suppl 11):5-10.
-
(2004)
J Clin Psychiatry
, vol.65
, Issue.SUPPL. 11
, pp. 5-10
-
-
Lawlor, B.A.1
-
23
-
-
0035009765
-
Selective serotonin reuptake inhibitors for late-life depression: A comparative review
-
Solai LK, Mulsant BH, Pollock BG. Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drugs Aging. 2001;18:355-368.
-
(2001)
Drugs Aging
, vol.18
, pp. 355-368
-
-
Solai, L.K.1
Mulsant, B.H.2
Pollock, B.G.3
|